These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4618080)

  • 21. Hypolipidemic activity of rifamycin derivatives.
    Traxler P; Kump W; Mueller K; Tosch W
    J Med Chem; 1990 Feb; 33(2):552-60. PubMed ID: 2299623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New derivatives of rifamycin SV. Esters, hydrazide amides of 3-carboxyrifamycin SV].
    Marchi E; Brufani M; Bellomo P
    G Ital Chemioter; 1979; 26(1-2):207-12. PubMed ID: 554811
    [No Abstract]   [Full Text] [Related]  

  • 23. Rifamycins do not function by allosteric modulation of binding of Mg2+ to the RNA polymerase active center.
    Feklistov A; Mekler V; Jiang Q; Westblade LF; Irschik H; Jansen R; Mustaev A; Darst SA; Ebright RH
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14820-5. PubMed ID: 18787125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface activity of drugs: oximes of 3-formylrifamycin SV.
    Pelizza G; Allievi GC; Gallo GG
    Farmaco Sci; 1976 Jan; 31(1):31-40. PubMed ID: 939317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cordycepin triphosphate on the nuclear DNA-dependent RNA polymerases and poly(A) polymerase from the yeast, Saccharomyces cerevisiae.
    Horowitz B; Goldfinger BA; Marmur J
    Arch Biochem Biophys; 1976 Jan; 172(1):143-8. PubMed ID: 766704
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent trends in rifamycin research.
    Lal R; Lal S
    Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the inhibition of poly(A) polymerase from rat liver and hepatoma 3924A by rifamycin SV derivatives.
    Nutter RC; Glazer RI
    Biochem Pharmacol; 1979 Aug; 28(16):2503-9. PubMed ID: 508367
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies of the topography of the binding site of DNA-dependent RNA polymerase from Escherichia coli for the antibiotic rifamycin SV.
    Stender W; Scheit KH
    Eur J Biochem; 1977 Jun; 76(2):591-600. PubMed ID: 330165
    [No Abstract]   [Full Text] [Related]  

  • 29. Subunit contacts of the rifamycin binding site of RNA polymerase (B. subtilis).
    Rice LS; Meares CF
    Biochem Biophys Res Commun; 1978 Jan; 80(1):26-32. PubMed ID: 414752
    [No Abstract]   [Full Text] [Related]  

  • 30. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the rifamycin dimers on the activities of nucleic acid polymerases from various sources. Relation between lipophily and toxicity.
    Talpaert-Borlé M; Campagnari F; Discenza G
    J Antibiot (Tokyo); 1975 Aug; 28(8):580-9. PubMed ID: 1158783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A derivative of rifamycin SV inhibiting rifampicin-resistant RNA polymerase of Escherichia coli.
    Nikiforov VG; Trapkova AA; Gragerov AI; Maslin DN
    FEBS Lett; 1982 Dec; 150(2):416-8. PubMed ID: 6761147
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular structure and conformation of rifamycin S, a potent inhibitor of DNA-dependent RNA polymerase.
    Arora SK; Arjunan P
    J Antibiot (Tokyo); 1992 Mar; 45(3):428-31. PubMed ID: 1577671
    [No Abstract]   [Full Text] [Related]  

  • 34. Rifampicin-resistant bacteriophage PBS2 infection and RNA polymerase in Bacillus subtilis.
    Price AR; Hitzeman R; Frato J; Lombardi K
    Nucleic Acids Res; 1974 Nov; 1(11):1497-502. PubMed ID: 10793705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interruption of oncornavirus replication by modified rifamycin antibiotics.
    O'Connor TE
    Ann N Y Acad Sci; 1977 Mar; 284():544-65. PubMed ID: 81643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of a rifamycin derivative (AF-013) which is active on the nucleic acid polymerases insensitive to rifampicin.
    Riva S; Fietta A; Silvestri LG
    Biochem Biophys Res Commun; 1972 Dec; 49(5):1263-71. PubMed ID: 4566674
    [No Abstract]   [Full Text] [Related]  

  • 37. The modification of DNA-dependent RNA polymerase from Escherichia coli by an alkylating derivative of rifamycin SV.
    Stender W; Stütz AA; Scheit KH
    Eur J Biochem; 1975 Aug; 56(1):129-36. PubMed ID: 1100387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A direct effect of some rifamycin derivatives on the morphology of mammalian mitochondria.
    Follett EA; Pennington TH
    Exp Cell Res; 1973 Mar; 77(1):47-56. PubMed ID: 4120443
    [No Abstract]   [Full Text] [Related]  

  • 39. Resistance in inhibitors of RNA polymerase in actinomycetes which produce them.
    Blanco MG; Hardisson C; Salas JA
    J Gen Microbiol; 1984 Nov; 130(11):2883-91. PubMed ID: 6084703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. R17 RNA replicase. V. Rifamycin sensitivity of R17 RNA synthesis in vivo.
    Igarashi SJ; Elliott FB
    J Biochem; 1975 Jun; 77(6):1261-9. PubMed ID: 773921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.